Familial multinodular goiter

Familial multinodular goiter (also known as familial nontoxic multinodular goiter or hereditary multinodular goiter) is a genetic condition characterized by the development of multiple nodules within the thyroid gland that runs in families. Unlike sporadic multinodular goiter, this condition has a clear hereditary component, with multiple family members across generations typically affected. The thyroid gland, located in the front of the neck, becomes enlarged and develops multiple benign nodular growths that can vary in size. These nodules may cause visible neck swelling, a sensation of pressure or fullness in the neck, difficulty swallowing (dysphagia), or difficulty breathing if the goiter becomes large enough to compress surrounding structures. In most cases, thyroid function remains normal (euthyroid state), though some individuals may develop hypothyroidism or, less commonly, hyperthyroidism over time. The condition primarily affects the endocrine system, specifically the thyroid gland. Several genetic loci have been implicated in familial multinodular goiter, including the MNG1 locus on chromosome 14q31 and other loci, though the precise genetic mechanisms remain incompletely understood. Mutations in genes such as DICER1 and thyroid-related transcription factors have been associated with some familial forms. Age of onset is variable but typically manifests in adolescence or adulthood, and the condition appears to be more common in women than in men, consistent with thyroid disease in general. Treatment depends on the size of the goiter, symptoms, and thyroid function. Observation with regular monitoring through thyroid ultrasound and thyroid function tests is appropriate for small, asymptomatic goiters. Levothyroxine suppression therapy may be considered in some cases to reduce thyroid-stimulating hormone (TSH) levels and potentially slow nodule growth, though its efficacy is debated. Surgical intervention (thyroidectomy) may be recommended for large goiters causing compressive symptoms, cosmetic concerns, or when malignancy cannot be excluded. Radioactive iodine therapy is another option for reducing goiter size in selected patients. Fine-needle aspiration biopsy of dominant or suspicious nodules is important to rule out thyroid cancer, as the risk of malignancy in multinodular goiter, while low, is not negligible. Genetic counseling is recommended for affected families.

Common questions about Familial multinodular goiter